Evans BE - Search Results

1

Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy termini.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Boger J, Poe M, LaMont BI, Lynch RJ, Ulm EH, Vlasuk GP, et al. Bock MG, et al. Among authors: evans be. J Med Chem. 1987 Oct;30(10):1853-7. doi: 10.1021/jm00393a029. J Med Chem. 1987. PMID: 3309316

2

Orally active, nonpeptide oxytocin antagonists.

Evans BE, Leighton JL, Rittle KE, Gilbert KF, Lundell GF, Gould NP, Hobbs DW, DiPardo RM, Veber DF, Pettibone DJ, et al. Evans BE, et al. J Med Chem. 1992 Oct 16;35(21):3919-27. doi: 10.1021/jm00099a020. J Med Chem. 1992. PMID: 1331449

3

Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DF, Freidinger RM, Chang RS, Chen TB, Lotti VJ. Bock MG, et al. Among authors: evans be. J Med Chem. 1990 Jan;33(1):450-5. doi: 10.1021/jm00163a069. J Med Chem. 1990. PMID: 2153212

4

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RS, et al. Evans BE, et al. J Med Chem. 1988 Dec;31(12):2235-46. doi: 10.1021/jm00120a002. J Med Chem. 1988. PMID: 2848124

5

Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM. Bock MG, et al. Among authors: evans be. J Med Chem. 1989 Jan;32(1):13-6. doi: 10.1021/jm00121a004. J Med Chem. 1989. PMID: 2909725 No abstract available.

6

Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potency.

Bock MG, DiPardo RM, Evans BE, Freidinger RM, Rittle KE, Payne LS, Boger J, Whitter WL, LaMont BI, Ulm EH, et al. Bock MG, et al. Among authors: evans be. J Med Chem. 1988 Oct;31(10):1918-23. doi: 10.1021/jm00118a009. J Med Chem. 1988. PMID: 3050088

7

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Veber DF, Freidinger RM, Chang RS, Lotti VJ. Bock MG, et al. Among authors: evans be. J Med Chem. 1988 Jan;31(1):176-81. doi: 10.1021/jm00396a028. J Med Chem. 1988. PMID: 3336017

8

Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.

Bock MG, DiPardo RM, Evans BE, Rittle KE, Freidinger RM, Chang RS, Lotti VJ. Bock MG, et al. Among authors: evans be. J Med Chem. 1988 Jan;31(1):264-8. doi: 10.1021/jm00396a042. J Med Chem. 1988. PMID: 3336026 No abstract available.

9

A uniquely potent renin inhibitor and its unanticipated plasma binding component.

Evans BE, Rittle KE, Bock MG, Bennett CD, DiPardo RM, Boger J, Poe M, Ulm EH, LaMont BI, Blaine EH, et al. Evans BE, et al. J Med Chem. 1985 Dec;28(12):1755-6. doi: 10.1021/jm00150a001. J Med Chem. 1985. PMID: 3906130 No abstract available.

10

Nanomolar-affinity, non-peptide oxytocin receptor antagonists.

Evans BE, Lundell GF, Gilbert KF, Bock MG, Rittle KE, Carroll LA, Williams PD, Pawluczyk JM, Leighton JL, Young MB, et al. Evans BE, et al. J Med Chem. 1993 Dec 10;36(25):3993-4005. doi: 10.1021/jm00077a002. J Med Chem. 1993. PMID: 8258821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters